Prof Jones is Chairman of the Oxford based Drug Discovery Company e-Therapeutics and a Board member of the U.S. pan coronavirus vaccine company ,Techimmune Inc.
He was formerly a Director of Allergan Inc. (USA), R&D Director of The Wellcome Foundation and Director General of the ABPI.
Prof Jones is a visiting professor at King’s College, London and holds honorary degrees and Gold Medals from six universities. He was a founder member of the Medicines for Malaria Venture (MMV), a member of The UK Government Regulatory Agency. The Medicines Commission advisor to the Cabinet Office on the Human Genome project, Chair of the UK Government Advisory Group on Genetics Research.
He is currently a member of the Wales Government, Bevan Commission on Health, was a Commissioner at The World Health Organisation, WHO, has advised the Government of the Netherlands TiPharma Board on Life Science and was a member of the EU Commission IMI Scientific Advisory Board.
He was the first winner of the SCRIP Life Time Achievement award.
Prof Trevor M Jones CBE FMedSci PhD DSc Hon FRCP FBPhS FRSM FRSC FLSW
